252 related articles for article (PubMed ID: 29367434)
1. Proteomics Profiling of CLL Versus Healthy B-cells Identifies Putative Therapeutic Targets and a Subtype-independent Signature of Spliceosome Dysregulation.
Johnston HE; Carter MJ; Larrayoz M; Clarke J; Garbis SD; Oscier D; Strefford JC; Steele AJ; Walewska R; Cragg MS
Mol Cell Proteomics; 2018 Apr; 17(4):776-791. PubMed ID: 29367434
[TBL] [Abstract][Full Text] [Related]
2. Proteomics and metabolomics identify molecular mechanisms of aging potentially predisposing for chronic lymphocytic leukemia.
Mayer RL; Schwarzmeier JD; Gerner MC; Bileck A; Mader JC; Meier-Menches SM; Gerner SM; Schmetterer KG; Pukrop T; Reichle A; Slany A; Gerner C
Mol Cell Proteomics; 2018 Feb; 17(2):290-303. PubMed ID: 29196338
[TBL] [Abstract][Full Text] [Related]
3. Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures.
Johnston HE; Carter MJ; Cox KL; Dunscombe M; Manousopoulou A; Townsend PA; Garbis SD; Cragg MS
Mol Cell Proteomics; 2017 Mar; 16(3):386-406. PubMed ID: 28062796
[TBL] [Abstract][Full Text] [Related]
4. Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy.
Daneshmanesh AH; Mikaelsson E; Jeddi-Tehrani M; Bayat AA; Ghods R; Ostadkarampour M; Akhondi M; Lagercrantz S; Larsson C; Osterborg A; Shokri F; Mellstedt H; Rabbani H
Int J Cancer; 2008 Sep; 123(5):1190-5. PubMed ID: 18546292
[TBL] [Abstract][Full Text] [Related]
5. Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia.
Baskar S; Kwong KY; Hofer T; Levy JM; Kennedy MG; Lee E; Staudt LM; Wilson WH; Wiestner A; Rader C
Clin Cancer Res; 2008 Jan; 14(2):396-404. PubMed ID: 18223214
[TBL] [Abstract][Full Text] [Related]
6. Use of the receptor tyrosine kinase-like orphan receptor 1 (ROR1) as a diagnostic tool in chronic lymphocytic leukemia (CLL).
Uhrmacher S; Schmidt C; Erdfelder F; Poll-Wolbeck SJ; Gehrke I; Hallek M; Kreuzer KA
Leuk Res; 2011 Oct; 35(10):1360-6. PubMed ID: 21531460
[TBL] [Abstract][Full Text] [Related]
7. A Murine Model of Chronic Lymphocytic Leukemia Based on B Cell-Restricted Expression of Sf3b1 Mutation and Atm Deletion.
Yin S; Gambe RG; Sun J; Martinez AZ; Cartun ZJ; Regis FFD; Wan Y; Fan J; Brooks AN; Herman SEM; Ten Hacken E; Taylor-Weiner A; Rassenti LZ; Ghia EM; Kipps TJ; Obeng EA; Cibulskis CL; Neuberg D; Campagna DR; Fleming MD; Ebert BL; Wiestner A; Leshchiner I; DeCaprio JA; Getz G; Reed R; Carrasco RD; Wu CJ; Wang L
Cancer Cell; 2019 Feb; 35(2):283-296.e5. PubMed ID: 30712845
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of B-cell receptor signaling in chronic lymphocytic leukaemia reveals a possible role for kininogen.
Kashuba E; Eagle GL; Bailey J; Evans P; Welham KJ; Allsup D; Cawkwell L
J Proteomics; 2013 Oct; 91():478-85. PubMed ID: 23938224
[TBL] [Abstract][Full Text] [Related]
9. Autocrine Signaling by Wnt-5a Deregulates Chemotaxis of Leukemic Cells and Predicts Clinical Outcome in Chronic Lymphocytic Leukemia.
Janovska P; Poppova L; Plevova K; Plesingerova H; Behal M; Kaucka M; Ovesna P; Hlozkova M; Borsky M; Stehlikova O; Brychtova Y; Doubek M; Machalova M; Baskar S; Kozubik A; Pospisilova S; Pavlova S; Bryja V
Clin Cancer Res; 2016 Jan; 22(2):459-69. PubMed ID: 26240275
[TBL] [Abstract][Full Text] [Related]
10. The significance of spliceosome mutations in chronic lymphocytic leukemia.
Rozovski U; Keating M; Estrov Z
Leuk Lymphoma; 2013 Jul; 54(7):1364-6. PubMed ID: 23270583
[TBL] [Abstract][Full Text] [Related]
11. STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia.
Debant M; Burgos M; Hemon P; Buscaglia P; Fali T; Melayah S; Le Goux N; Vandier C; Potier-Cartereau M; Pers JO; Tempescul A; Berthou C; Bagacean C; Mignen O; Renaudineau Y
J Immunother Cancer; 2019 Apr; 7(1):111. PubMed ID: 31014395
[TBL] [Abstract][Full Text] [Related]
12. Noncoding RNA genes in cancer pathogenesis.
Pekarsky Y; Croce CM
Adv Biol Regul; 2019 Jan; 71():219-223. PubMed ID: 30611710
[TBL] [Abstract][Full Text] [Related]
13. Multipronged functional proteomics approaches for global identification of altered cell signalling pathways in B-cell chronic lymphocytic leukaemia.
Díez P; Lorenzo S; Dégano RM; Ibarrola N; González-González M; Nieto W; Almeida J; González M; Orfao A; Fuentes M
Proteomics; 2016 Apr; 16(8):1193-203. PubMed ID: 26910488
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia.
Gagro A; Dasić G; Sabioncello A; Rabatić S; Reckzeh B; Havemann K; Kardum I; Jacksić B; Vitale B
Leuk Lymphoma; 1997 Apr; 25(3-4):301-11. PubMed ID: 9168440
[TBL] [Abstract][Full Text] [Related]
15. Identification of new phosphorylation sites of CD23 in B-cells of patients with chronic lymphocytic leukemia.
Maďarová M; Mucha R; Hresko S; Makarová Z; Gdovinová Z; Szilasiová J; Vitková M; Guman T; Štecová N; Dobransky T
Leuk Res; 2018 Jul; 70():25-33. PubMed ID: 29763855
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease.
Pallasch CP; Schulz A; Kutsch N; Schwamb J; Hagist S; Kashkar H; Ultsch A; Wickenhauser C; Hallek M; Wendtner CM
Blood; 2008 Nov; 112(10):4213-9. PubMed ID: 18708628
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia.
Ferreira PG; Jares P; Rico D; Gómez-López G; Martínez-Trillos A; Villamor N; Ecker S; González-Pérez A; Knowles DG; Monlong J; Johnson R; Quesada V; Djebali S; Papasaikas P; López-Guerra M; Colomer D; Royo C; Cazorla M; Pinyol M; Clot G; Aymerich M; Rozman M; Kulis M; Tamborero D; Gouin A; Blanc J; Gut M; Gut I; Puente XS; Pisano DG; Martin-Subero JI; López-Bigas N; López-Guillermo A; Valencia A; López-Otín C; Campo E; Guigó R
Genome Res; 2014 Feb; 24(2):212-26. PubMed ID: 24265505
[TBL] [Abstract][Full Text] [Related]
18. Elucidating the CXCL12/CXCR4 signaling network in chronic lymphocytic leukemia through phosphoproteomics analysis.
O'Hayre M; Salanga CL; Kipps TJ; Messmer D; Dorrestein PC; Handel TM
PLoS One; 2010 Jul; 5(7):e11716. PubMed ID: 20661426
[TBL] [Abstract][Full Text] [Related]
19. Total proteome analysis identifies migration defects as a major pathogenetic factor in immunoglobulin heavy chain variable region (IGHV)-unmutated chronic lymphocytic leukemia.
Eagle GL; Zhuang J; Jenkins RE; Till KJ; Jithesh PV; Lin K; Johnson GG; Oates M; Park K; Kitteringham NR; Pettitt AR
Mol Cell Proteomics; 2015 Apr; 14(4):933-45. PubMed ID: 25645933
[TBL] [Abstract][Full Text] [Related]
20. CD47 agonist peptides induce programmed cell death in refractory chronic lymphocytic leukemia B cells via PLCγ1 activation: evidence from mice and humans.
Martinez-Torres AC; Quiney C; Attout T; Boullet H; Herbi L; Vela L; Barbier S; Chateau D; Chapiro E; Nguyen-Khac F; Davi F; Le Garff-Tavernier M; Moumné R; Sarfati M; Karoyan P; Merle-Béral H; Launay P; Susin SA
PLoS Med; 2015 Mar; 12(3):e1001796. PubMed ID: 25734483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]